Page last updated: 2024-11-05

trihexyphenidyl and CACH Syndrome

trihexyphenidyl has been researched along with CACH Syndrome in 2 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research Excerpts

ExcerptRelevanceReference
" All our patients underwent continuous infusion of midazolam, in association with pimozide and trihexyphenidyl, which led to complete resolution of muscular spasms in two patients."3.78Management of status dystonicus in children. Cases report and review. ( Balestri, P; Grosso, S; Messina, M; Sacchini, M; Verrotti, A, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bamford, A1
Crowe, BH1
Hacohen, Y1
Lin, JP1
Clarke, A1
Tudor-Williams, G1
Sancho-Shimizu, V1
Vincent, A1
Lim, M1
Pullaperuma, SP1
Grosso, S1
Verrotti, A1
Messina, M1
Sacchini, M1
Balestri, P1

Other Studies

2 other studies available for trihexyphenidyl and CACH Syndrome

ArticleYear
Pediatric Herpes Simplex Virus Encephalitis Complicated by N-Methyl-D-aspartate Receptor Antibody Encephalitis.
    Journal of the Pediatric Infectious Diseases Society, 2015, Volume: 4, Issue:2

    Topics: Acyclovir; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antiviral Agents; Autoantibodies; Clonid

2015
Management of status dystonicus in children. Cases report and review.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2012, Volume: 16, Issue:4

    Topics: Adolescent; Anti-Dyskinesia Agents; Baclofen; Brain; Case Management; Child; Cysts; Dystonia; Electr

2012